NCT01414374已完成3 期
Prevalence of Genetic Polymorphisms of DMT1 and Ferroportin Enzymes in Adults With Anemia by Iron Deficiency, and Its Influence on the Efficacy of Conventional and Herbal Treatments
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Hemoglobin
研究概览
简要总结
The study aims to investigate the prevalence of genetic polymorphisms in adults with iron deficiency and anemia, and the responses to two different treatments: iron sulphate and a composite herbal medicine (Hibiscus sabdariffa plus Centella asiatica). The main outcome will be hemoglobin, measured before and after 6 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age > 18 y and < 50 y
- •A diagnostic of iron deficient anemia
排除标准
- •Severe anemia
- •Treatment interruption for more than 25% of the 6 weeks
- •New onset severe adverse symptoms or events
- •Patient's request
研究组 & 干预措施
Iron
Active Comparator
干预措施: Iron (Drug)
Herbal
Experimental
干预措施: Herbal medicine (Drug)
结局指标
主要结局
Hemoglobin
时间窗: 6 weeks
Hemoglobin will be measured before treatment and after 6 weeks of treatment
次要结局
未报告次要终点
研究者
Fabio Carmona
Assistant Professor
University of Sao Paulo
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Epidemiological Study of Iron Deficiency and Iron Deficiency Anemia in Chinese Pregnant WomenAnemia, Iron-DeficiencyNCT02887963West China Hospital12,000
已完成
不适用
How Does Iron Supplementation Affect Training and Performance in Female Collegiate Rowers?Iron Deficiency (Without Anemia)NCT01383798Cornell University40
已完成
不适用
Hemochromatosis and Iron Overload Screening Study (HEIRS)Iron OverloadBlood DiseaseHemochromatosisNCT00005541National Heart, Lung, and Blood Institute (NHLBI)
已完成
不适用
Prevalence of FID and QoL in Patients with Oncological and with Haematological MalignanciesFunctional Iron DeficiencyNCT05333913Luzerner Kantonsspital160
已完成
不适用
Pharmacogenetic Study in Patients Received Iron Chelating AgentHemosiderosisNCT01623895Seoul National University Hospital100